Core Products
Focus on Developing Undruggable Targets and First-in-Class Innovative Drugs
Cothera Bioscience is focusing on developing therapeutics for previous undruggable oncology targets with high unmet medical needs. Current pipeline includes three clinical stage programs targeting Myc and KRAS.